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Bromoflavones were treated with various terminal alkynes in palladium-catalyzed cross-coupling 
reactions under phosphine-free condions to give the expected alkenylated flavones in moderate 
to good yields. The presence of two different β hydrogens in the terminal alkene led to the 
formation of both alkenylated and alkylated products. 
 






Flavones are relatively common natural products in the Plant Kingdom. They play important 
roles in the plant reproduction and defense and also possess a wide range of biological and 
pharmaceutical activities.1 Both natural and synthetic derivatives show marked antiproliferative, 
anticarcinogenic or antitumor effect2 and, among others, antioxidant,3 anticonvulsive,4 α-
glucosidase inhibitor,5 aldehyde dehydrogenase ALDH-2 inhibitor,6 EGFR tyrosine kinase7 and 
COX-2 inhibiting activity.8 
The group of 2- and 3-styrylchromones is a smaller family of chromonoids9,10 but few 
representatives are known in the nature and their biological activities were also reported and 
reviewed.11 Much less has been reported about 3-styrylflavones.12 The first contribution is 
related to Parthasarathy’s group in the early 90’s,12a they have synthetized the target 3-
styrylflavone from 3-methylflavone by using Wittig reaction. Another synthetic approach based 
on the condensation of 1-(2-hydroxyphenyl)-3-phenylpropane-1,3-diones and 
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phenylacetaldehydes.12b An interesting synthesis of 3-vinyl- or 3-(1-propenyl)flavones and 
related systems by using an acid-catalyzed retro-Michael ring opening of 3-acylchromanones 
was also published.13  
An alternative approach to alkenylchromones and flavones is the palladium-catalyzed cross-
coupling reaction (Heck reaction) of halochromones or –flavones with various alkenes. 
Surprisingly, only sporadic contributions were presented till the end of the last decade.14 
Recently, we presented the results of our detailed studies on the Heck reaction of various 
bromochromones and their derivatives with a protected ortho-hydroxy group. It was proved that 
this effective reaction offers a new entry to naturally occurring derivatives.15 Presence of the 
ortho-hydroxy functionality allows a ring-closure to give tricyclic systems. In this contribution 
we wish to display some of our results in the field of cross-coupling of bromoflavones. 
Obviously, this new alkenylation methodology opens up a new way to a wide group of natural 






































Several flavones or isoflavones with an alkenyl side-chain or 2-arylfuro- or -pyranochromone 
structure show biological activity. For instance, anadanthoflavone is active against both human 
platelet 12-lipoxygenase and human reticulocyte 15-lipoxygenase,17 isoartocarpesin inhibits 
tyrosinase and, thus, melanin biosynthesis.18 Carpachromene had considerable cytotoxic effect 
against various cell lines.19b Atalantoflavone was found to be active against the plant pathogen 
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Results and Discussion 
 
Alkenylation of flavone ring system at position 3 was tested first. The starting material 3-
bromoflavones 4-6 were prepared by an N-bromosuccinimide (NBS) bromination of the 
corresponding flavones 1-3 in the presence of substoichiometric amount of pyridine,22 the yields 
varied in wide range depending on the substituent in position 4’. Our previous studies in the field 
of bromochromones showed the high efficiency of the phoshine-free conditions using quaternary 
ammonium salts frequently cited as Jeffery’s conditions.15 To our delight this method 
(Conditions A) worked well in the case of 3-bromoflavones 4-6, too (Scheme 1, Table 1). The 
reactions of 3-bromoflavones 4,5 with styrenes 7a-d gave the expected 3-styrylflavones 8a-d, 
9a,b in moderate to good (51-95%) yields (Table 1, Entries 1-4, 8,9). The reactivity of 3-bromo-
4’-chloroflavone (6), however, was considerably lower, a poor (45%) yield was found even at 
elevated temperature and extended reaction period (Table 1, Entry 11). Other terminal alkenes 
such as 2-methylbut-3-en-2-ol (7e) or ethyl acrylate (7f) led also to the desired products 8e,f, 9f 
and 10f but a higher temperature and longer reaction period was needed for the completion of the 
reaction in the case of ethyl acrylate (7f) (Table 1, Entries 6,10,14). In the reaction of 3-
bromochromone (4) and ethyl acrylate (7f) we have also tested the phosphine-containing 
conditions (Conditions B, Scheme 1) but no improvement of the yield was observed even at 155 
oC (Table 1, Entry 7). The low reactivity of substrate 6 was found, again. Its reaction with 
butenol 7e failed to give the expected product 10e under Conditions A or B (Table 1, Entries 
12,13). The reason of the decreased reactivity is not clear, the electron-withdrawing chlorine 




Scheme 1. Conditions A: Pd(OAc)2, K2CO3, tetrabutylammonium bromide (TBAB), KCl, 
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Table 1. Reaction of 3-bromoflavones 4-6 with various terminal alkenes 7a-f 






1 4 8a A 100 35 76 
2 4 8b A 110 30 95 
3 4 8c A 110 30 77 
4 4 8d A 110 40 94 
5 4 8e A 110 25 81 
6 4 8f A 140 240 65 
7 4 8f B 155 150 69 
8 5 9a A 110 50 51 
9 5 9b A 110 45 94 
10 5 9f A 140 60 76 
11 6 10a A 140 540 45 
12 6 10e A 140 3 days traces 
13 6 10e B 140 20 h traces 
14 6 10f A 140 40 45 
 
As usual, the cross-coupling reactions took place with complete diastereoselectivity, only the 
thermodynamically more stable E alkenes were obtained. The relative configuration was proven 
by the high (ca. 16 Hz) value of 3JH,H coupling constants of the vinylic hydrogens. Most of these 
products were hitherto unknown in the literature. 
We also investigated the Heck reaction of 6-bromo- (15) and 7-bromoflavone (16). The 
necessary starting materials 13,14 were prepared by our oxidative cyclization methodology23 and 
their reaction with the substituted styrenes 7a-d and 2-methylbut-3-en-2-ol (7e) gave the 
corresponding E-alkenes 15,16 smoothly and usually in good yields (Scheme 2, Table 2). 
It is noteworthy that ethyl acrylate (7f) reacted more sluggishly, again. Only reactions under 
Conditions B at higher (160 oC) temperature and long reaction periods afforded the desired 
acrylates 15f and 16f. To our best knowledge, this is the first reported synthesis flavones having 
1-alkenyl groups in their Ring A.  
In addition, we studied the cross-coupling of 6-bromoflavone (13) with acrolein diethyl 
acetal (17) and, in accordance with our observation made in the bromochromone series,15a  two 
products were isolated. The major one was ethyl (E)-6-(2-phenyl-4-oxo-4H-1-benzopyran-3-
yl)propionate (19) while the minor one was identified as the expected acrylaldehyde (18). The 
reason of this double reactivity is the presence of two different β hydrogens in contrast with the 
previous terminal alkenes having only one β hydrogen. The competitive β and β’ hydride 
eliminations in the catalytic cycle gave these two products.14a,15 This double reactivity pattern 
seems to be characteristic for Jeffery’s conditions and allows the synthesis of 
flavonylpropionates by Heck reaction.  
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Scheme 2. Conditions A: Pd(OAc)2, K2CO3, tetrabutylammonium bromide (TBAB), KCl, 




Table 2. Reaction of 6-bromoflavone (13) and 7-bromoflavone (14) with various terminal 
alkenes 7a-f 






1 13 15a A 110 60 87 
2 13 15b A 110 40 88 
3 13 15c A 110 30 41 
4 13 15d A 110 30 87 
5 13 15e A 110 30 77 
6 13 15f B 160 300 32 
7 14 16a A 110 60 65 
8 14 16b A 110 60 92 
9 14 16c A 110 40 89 
10 14 16d A 110 90 68 
11 14 16e A 110 40 76 
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In conclusion, our previous synthetic route developed for the synthesis of alkenylated chromones 
was successfully extended to flavones as we demonstrated that Heck reaction of various 
bromoflavones under modified Jeffery’s conditions resulted in a wide range of hitherto unknown 
alkenylated flavones in good yields. This efficient methodology opens up the way not only to 
flavonyl alkenes but also to naturally occurring flavone derivatives with resacetophenone or 
phloroacetophenone-type substitution pattern. The competitive β and β’ hydride eliminations 




General. Chromatographic separations were performed using silica gel (Merck, 70-230 mesh). 
Thin-layer chromatography was carried out on Kieselgel 60 F254 (0.25 mm layer thickness, 
Merck). Melting points were determined on a Boetius hot-stage apparatus and are uncorrected. 
1H NMR and 13C NMR spectra were recorded with a Bruker AM 360 (360 MHz for 1H; 90 MHz 
for 13C nuclei) spectrometer in CDCl3 solution unless otherwise specified (internal standard 
TMS, δ = 0 ppm or residual peaks CHCl3 (δ = 7.26 ppm) for 1H NMR and (δ = 77.00) for 13C 
NMR). 13C NMR assignments were supported by J-echo technique. IR spectra were recorded 
with a Perkin-Elmer 16 PC-FT-IR or Jasco FT-IR 4100A instrument in KBr disks. Elemental 
analyses were performed in house with an Elementar Vario MicroCube instrument.  
 
Bromoflavones. 3-Bromoflavones 4-6 were prepared according to a literature procedure22 by 
heating the corresponding flavones 1a-b with 1.67 equiv. of N-bromosuccinimide (NBS) and 
0.25 equiv. of pyridine in dry carbon tetrachloride (12 mL). 3-Bromoflavone (4)24 and 3-
bromoflavones 5,625 were identified by their literature mp values and NMR spectra. Yields: 77% 
(4), 26% (5), 44% (6). 6-Bromoflavone (13) and 7-bromoflavone (14) were synthetized by our 
methodology (iodine-catalyzed dehydrogenation in hot DMSO solution).23 Bromoflavones 1326 
and 1427 were identified by their literature mp values and NMR characteristics. Yields: 53% (13), 
66% (14). 
 
General procedure for the synthesis of alkenylated flavones 
Conditions A. A mixture of bromoflavone 4-6, 11,13 (1.25 mmol), potassium carbonate (1.87 
mmol), potassium chloride (1.25 mmol), TBAB (2.52 mmol), palladium(II) acetate (0.08 mmol) 
and alkene 7a-f (4.16 mmol) in DMF (10 mL) was heated at the temperature given in Tables 1 
and 2 in an oil bath under nitrogen atmosphere. After the completion of reaction (TLC 
monitoring, hexane-ethyl acetate = 1:1, v/v) the mixture was poured into water, the precipitation 
was filtered off and purified by recrystallization or by column chromatography. When the 
product did not precipitate the mixture was extracted with diethyl ether (3x35 mL), the combined 
organic layers were washed with water, dried (MgSO4) and concentrated under reduced pressure. 
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Conditions B. A mixture of bromoflavone 4-6, 11,13 (1.25 mmol), TEA (1.39 mmol), TPP (0.12 
mmol), palladium(II) acetate (0.008 mmol) and alkene 7a-f (4.16 mmol) in NMP (10 mL) was 
heated (see Tables 1 and 2) in an oil bath under nitrogen atmosphere. After the completion of 
reaction (TLC monitoring, hexane-ethyl acetate = 1:1, v/v) the mixture was worked up as stated 
above. 
(E)-3-Styrylflavone (8a). Method A, reaction period: 35 min. Recrystallization from hexane-
ethyl acetate. Yield: 76%. Brownish crystalline powder, mp 173-174 °C. IR: νmax 3061, 1641 
(C=O), 1614 (C=C), 1545, 1467, 1390 (flavone skeleton), 1231, 964 (CH=CH, trans), 769, 754, 
700 cm-1; 1H NMR: δ 6.83 (d, J = 16.1 Hz, 1H, β-H), 7.25-7.75 (m, 14H, Ar-H), 8.02 (d, J = 
16.1 Hz, 1H, α-H), 8.31 (d, J = 7.6 Hz, 1H, 5-H); 13C-NMR: δ 117.5 (C-3), 117.8 (C-8), 120.0 
(C-β), 123.5 (C-4a), 125.0 (C-α), 126.2 (C-6), 126.4, 128.5, 129.8 (2’,6’-C, 2”,6”-C, 3’,5’-C, 
3”,5”-C), 127.5 (C-4”), 130.7 (C-4’), 133.1 (C-1’), 134.3 (C-5), 138.1 (C-7), 155.3 (C-1”), 163.0 
(C-8a), 165.8 (C-2), 177.4 (C-4). Anal. Calcd. for C23H16O2 (324.38): C, 85.16; H, 4.97%. 
Found: C, 84.98; H, 5.11%. 
(E)-3-(4-Methylstyryl)flavone (8b). Method A, reaction period: 30 min.  Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 95%. Yellow powder, mp 160-
161 °C. IR: νmax 3016, 1639 (C=O), 1614 (C=C), 1547, 1464, 1396 (flavone skeleton), 1227, 
1176, 1115, 967 (HC=CH, trans), 772, 755, 704 cm-1; 1H NMR: δ 2.31 (s, 3H, CH3), 6.75 (d, J = 
16.1 Hz, 1H, β-H), 7.08 (d, J = 7.7 Hz, 2H, 3”,5”-H), 7.26 (d, J = 7.7 Hz, 2H, 2”,6”-H), 7.38-
7.53 (m, 5H, 6-H, 8-H, 3’,5’-H, 4’-H), 7.63 (m, 1H, 7-H), 7.73 (m, 2H, 2’,6’-H), 7.95 (d, J = 
16.1 Hz, 1H, α-H); 8.30 (d, J = 7.7 Hz, 1H, 5-H); 13C-NMR: δ 21.1 (CH3), 117.7 (C-8), 117.8 
(C-3), 119.0 (C-β), 123.5 (C-4a), 124.9, 126.2 (C-6, C-4’), 126.3 (C-3’,5’), 128.4, 129.2, 129.7 
(C-2’,6’, C-2”,6”, C-3”,5”), 130.7 (C-α), 133.2 (C-1’), 133.3 (C-5), 134.3 (C-7), 135.3 (C-1”), 
137.3 (C-4”), 155.3 (C-8a), 165.2 (C-2), 177.4 (C-4). Anal. Calcd. for C24H18O2 (338.41): C, 
85.18; H, 5.36%. Found: C, 85.29; H, 5.44%. 
(E)-3-(4-Methoxystyryl)flavone (8c). Method A, reaction period: 30 min. Recrystallization 
from hexane – abs. ethanol. Yield: 77%. Brownish crystalline powder, mp 114-116 °C. IR: νmax 
3077, 2960, 2833 (CH3O), 1636 (C=O), 1613 (C=C), 1509, 1443, 1390 (flavone skeleton), 1304, 
1278, 1245 (C-O-C), 1181, 1172, 1110, 1036 (C-O-C), 970 (HC=CH, trans), 820, 777, 762, 704 
cm-1; 1H NMR: δ 3.79 (s, 3H, CH3O), 6.61 (d, J = 16.8 Hz, 1H, β-H), 6.82 (d, J = 9.1 Hz, 2H, 
3”,5”-H); 7.30 (d, J = 9.1 Hz, 2H, 2”,6”-H); 7.32-7.48 (m, 2H, 6-H, 8-H), 7.58-7.60 (m, 3H, 
3’,5’-H, 4’-H), 7.63 (m, 1H, 7-H), 7.72 (m, 2H, 2’,6’-H); 7.94 (d, J = 16.8 Hz, 1H, α-H), 8.30 (d, 
J = 8.4 Hz, 1H, 5-H); 13C-NMR: δ 55.2 (CH3O), 113.9 (C-3”,5”), 117.7 (C-3), 117.8, 117.9 (C-8, 
C-β), 123.4 (C-4a), 124.9 (C-6), 126.2 (C-4’), 127.6, 128.4, 129.7 (C-2’,6’, C-3’,5’, C-2”,6”); 
130.5 (C-α), 130.9 (C-1’,1”), 133.3, 133.9 (C-5, C-7), 155.3 (C-8a), 159.2 (C-4”), 162.5 (C-2), 
177.5 (C-4). Anal. Calcd. for C24H18O3 (354.41): C, 81.34, H, 5.12%. Found: C, 81.50; H, 
5.07%. 
(E)-3-(4-Chlorostyryl)flavone (8d). Method A, reaction period: 40 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 94%. Yellow crystalline 
powder, mp 146-148 °C. IR: νmax 3058, 1640 (C=O), 1611 (C=C), 1543, 1491, 1465, 1445, 1395 
Issue in Honor of Prof. Ferenc Fülöp  ARKIVOC 2012 (v) 210-225 
 Page 217 ©ARKAT-USA, Inc. 
 
(flavone skeleton), 1336, 1312, 1292, 1228, 1118, 1095, 1078, 968 (HC=CH, trans), 915, 
821,769, 757, 700 cm-1; 1H NMR: δ 6.75 (d, J = 16.1 Hz, 1H, β-H), 6.79-7.29 (m, 4H, 2”,3”-H, 
5”,6”-H), 7.40-7.48 (m, 2H, 6, 8-H), 7.55 (m, 3H, 3’, 5’-H, 4’-H), 7.64 (m, 1H, 7-H), 7.71 (m, 
2H, 2’,6’-H), 7.97 (d, J = 16.1 Hz, 1H, α-H), 8.29 (d, J = 8.3 Hz, 1H, 5-H); 13C-NMR: δ 117.2 
(C-3), 117.8 (C-8), 120.7 (C-β), 123.4 (C-4a), 125.1 (C-6), 126.2 (C-4’), 127.5, 128.5, 128.6, 
129.7 (C-2’,6’, C-3’,5’, C-2”,6”, C-3”,5”),  130.8 (C-8), 132.9, 133.5 (C-5, C-α), 133.0 (C-1’, C-
4”), 136.6 (C-1”), 155.3 (C-8a), 163.2 (C-2), 177.3 (4-C). Anal. Calcd. for C23H15ClO2 (358.82): 
C, 76.99; H, 4.21%. Found: C, 80.11; H, 4.39%.  
(E)-3-(3-Hidroxy-3-methylbut-1-enyl)flavone (8e). Method A, reaction period: 25 min. 
Purified by column chromatography (eluent: toluene-ethyl acetate = 4:1, v/v). Yield: 81%. 
Yellow crystalline powder, mp 103-104 °C. IR: νmax 3420 (OH), 2975, 1640 (C=O), 1619 (C=C), 
1543, 1466, 1399 (flavone skeleton), 1372, 1268 (C-O), 1235, 1203, 1157, 1121, 985 (CH=CH, 
trans), 916, 783, 758, 708 cm-1; 1H NMR: δ 1.33 (s, 6H, 2xCH3), 1.68 (s, 1H, OH), 6.38 (d, J = 
16.1 Hz, 1H, 2”-H), 7.01 (d, J = 16.1 Hz, 1H, 1”-H), 7.40-7.52 (m, 5H, 6-H, 8-H, 3’,5’-H, 4’-H), 
7.64-7.69 (m, 3H, 7-H, 2’,6’-H), 8.26 (d, J = 7.7 Hz, 1H, 5-H); 13C-NMR: δ 29.6 (2xCH3), 71.2 
(C-3”), 117.3, 117.7 (C-8, C-1”), 117.5 (C-3),  123.3 (C-4a), 125.0, 126.1 (C-6, C-4’), 128.3 (C-
3’,5’), 129.6 (C-2’,6’), 130.5 (C-2”), 133.1 (C-1’), 133.4 (C-5), 143.9 (C-7), 155.4 (C-8a), 162.5 
(C-2), 177.5 (C-4). Anal. Calcd. for C20H18O3 (306.36): C, 78.41; H, 5.92%. Found: C, 78.35; H, 
5.85%.
 
Ethyl (E)-3-(2-phenyl-4-oxo-4H-1-benzopyran-3-yl)acrylate (8f). Method A, reaction period: 
240 min. Recrystallization from hexane – abs. ethanol. Yield: 65%. Method B, reaction period: 
155 min. Recrystallization from diisopropyl ether. Yield: 69%. Brownish crystalline powder, mp 
153-154 °C. IR: νmax 2976 (CH3), 1711 (C=O, ester), 1653 (C=O, ketone), 1616 (C=C), 1467, 
1400 (flavone skeleton), 1297, 1276 (C-O-C), 754, 689 cm-1; 1H NMR: δ 1.26 (t, J = 7.0 Hz, 3H, 
CH3CH2), 4.17 (q, J = 7.0 Hz, 2H, CH3CH2), 7.42-7.50 (m, 4H, 6’-H, 8’-H, 4”-H, 2-H), 7.52-
7.59 (m, 3H, 7-H, 3”,5”-H), 7.65-7.72 (m, 3H, 2”,6”-H, 3-H), 8.28 (d, J = 7.7 Hz, 1H, 5’-H); 
13C-NMR: δ 14.2 CH3CH2), 60.2 (CH3CH2), 115.4 (C-3’), 117.8 (C-8’), 123.3 (C-2), 125.5, 
126.3 (C-6’, C-4”), 128.6 (C-3”,5”), 129.8 (C-2”,6”), 131.4 (C-5’), 132.1 (C-1”), 133.8 (C-7’),  
135.9 (C-3), 155.2 (C-8a’), 166.7, 167.8 (C-2’, C-1), 176.8 (C-4’). Anal. Calcd. for C20H16O4 
(320.34): C, 74.99; H, 5.03%. Found: C, 74.79; H, 5.16%.  
(E)-4’-Methyl-3-styrylflavone (9a). Method A, reaction period: 50 min. Recrystallization from 
diisopropyl ether. Yield: 51 %. Light yellow crystalline powder, mp 124-125 °C. IR: νmax 3019, 
1640 (C=O), 1613 (C=C), 1549, 1467, 1387 (flavone skeleton), 1228, 1186, 1106, 966 (CH=CH, 
trans), 817, 755, 699 cm-1; 1H NMR: δ 2.48 (s, 3H, CH3), 6.84 (d, J = 16.1 Hz, 1H, β-H), 7.20-
7.49 (m, 9H, Ar-H), 7.64-7.69 (m, 3H, 7-H, 2’,6’-H), 8.04 (d, J = 16.1 Hz, 1H, α-H), 8.31 (d, J = 
7.2 Hz, 1H, 5-H); 13C-NMR: δ 21.5 (CH3), 117.2 (C-3), 117.7 (C-8), 120.3 (C-β), 123.5 (C-4a), 
124.9, 126.1, 127.3 (C-6, C-4”, C-α), 126.4 (C-3”,5”), 128.5, 129.1, 129.7 (C-2’,6’, C-3’,5’, C-
2”,6”), 130.2 (C-1’), 133.3, 134.0 (C-5, C-7), 138.2 (C-1”), 141.1 (C-4’), 155.3 (C-8a), 163.2 (C-
2), 177.4 (C-4). Anal. Calcd. for C24H18O2 (338.41): C, 85.18; H, 5.36%. Found: C, 85.07; H, 
5.35%. 
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(E)-3-(3-Hidroxy-3-methylbut-1-enyl)-4’-methylflavone (9e). Method A, reaction period: 45 
min. Purified by column chromatography (eluent: toluene-ethyl acetate = 4:1, v/v). Yield: 94 %. 
Light yellow crystalline powder, mp 75-76 °C. IR: νmax 3426 (OH), 2973, 1643 (C=O), 1613 
(C=C), 1545, 1466, 1394 (flavone skeleton), 1266 (C-OH), 1234, 1110, 918, 758 cm-1; 1H NMR: 
δ 1.35 (s, 6H, 2xCH3), 2.35 (s, 1H, OH), 2.44 (s, 3H, 4’-CH3), 6.35 (d, J = 16.1 Hz, 1H, 1”-H), 
7.03 (d, J = 16.1 Hz, 1H, 2”-H), 7.31 (d, J = 7.8 Hz, 2H, 3’,5’-H), 7.38-7.46 (m, 2H, 6-H, 8-H), 
7.59 (d, J = 7.8 Hz, 2H, 3’,5’-H), 7.55 (m, 1H, 7-H), 8.25 (d, J = 8.7 Hz, 1H, 5-H); 13C-NMR: δ 
21.4 (4’-CH3), 29.7 (2xCH3), 71.2 (C-3”), 117.1 (C-3), 117.5, 117.7 (C-8, C-1”), 123.3 (C-4a), 
124.9, 126.1 (C-6, C-2”), 129.0, 129.5 (C-2’,6’, C-3’,5’), 130.2 (C-1’), 133.2 (C-5), 140.9 (C-
4’), 143.6 (C-7), 155.4 (C-8a), 162.7 (C-2), 177.5 (C-4). Anal. Calcd. for C21H20O3 (320.39): C, 
78.73; H, 6.29%. Found: C, 78.92; H, 6.21%. 
Ethyl (E)-3-[2-(4-methylphenyl)-4-oxo-4H-1-benzopyran-3-yl]acrylate (9f). Method A, 
reaction period: 60 min. Recrystallization from diisopropyl ether. Yield: 76%. White fluffy 
leaflets, mp 147-148 °C. IR: νmax 2978, 1712 (C=O, ester), 1654 (C=O, ketone), 1614 (C=C), 
1467, 1396 (flavone skeleton), 1297, 1287, 1273 (C-O-C), 1165, 756 cm-1; 1H NMR: δ 1.29 (t, J 
= 7.0 Hz, 3H, CH3CH2), 2.46 (s, 3H, 4’-CH3), 4.18 (q, J = 7.0 Hz, CH3CH2), 7.34 (d, J = 8.1 Hz, 
2H, 3’,5’-H), 7.42-7.52 (m, 4H, 6-H, 8-H, 2”-H, 3”-H) 7.55 (d, J = 8.1 Hz, 2H, 2’,6’-H), 7.67 
(m, 1 H, 7-H), 8.27 (d, J = 8.4 Hz, 1H, 5-H); 13C-NMR: δ 14.2 (CH3CH2), 21.5 (4’-CH3), 60.2 
(CH3CH2), 115.2 (C-3), 117.9 (C-9), 123.0 (C-2”), 123.4 (C-4a), 125.4, 126.2 (C-5, C-6), 129.2 
(C-1’), 129.3, 129.8 (C-2’,6’, C-3’,5’), 133.8 (C-7), 136.3 (C-3”), 142.0 (C-4’), 155.2 (C-8a), 
167.0, 167.9 (C-2, C-1”), 176.8 (C-4). Anal. Calcd. for C21H18O4 (334.37): C, 75.43; H, 5.43%. 
Found: C, 75.35; H, 5.54%. 
(E)-4’-Chloro-3-styrylflavone (10a). Method A, reaction period: 540 min. Recrystallization 
from diisopropyl ether. Yield: 45%. Brownish crystalline powder, mp 180-181 °C. IR: νmax 3062, 
3025, 1644 (C=O), 1614 (C=C), 1595, 1487, 1467, 1406, 1389 (flavone skeleton), 1090 (Ar-Cl), 
1016, 835, 756, 700 cm-1; 1H NMR: δ 6.77 (d, J = 16.0 Hz, 1H, β-H), 7.21-7.53 (m, 8H, Ar-H), 
7.69-7.71 (m, 2H, 2’,6’-H), 7.81 (m, 1H, 7-H), 7.79 (d, J = 16.0 Hz, 1H, α-H), 8.29 (d, J = 7.2 
Hz, 1H, 5-H); 13C-NMR: δ 115.3 (C-3), 117.7 (C-8), 119.4 (C-β), 123.4 (C-4a), 125.2 (C-6), 
126.5 (C-3”,5”), 127.7 (C-4”), 128.6, 128.9 (C-3’,5’, C-2”,6”), 130.7 (C-α), 131.1 (C-2’,6’), 
131.5 (C-1’), 133.5 (C-5), 134.9 (C-7), 136.9, 137.9 (C-4’, C-1”), 155.3 (C-8a), 167.8 (C-2), 
177.2 (C-4). Anal. Calcd. for C23H15ClO2 (358.82): C, 76.99; H, 4.21%. Found: C, 77.11; H, 
4.24%. 
Ethyl (E)-3-[2-(4-chlorophenyl)-4-oxo-4H-1-benzopyran-3-yl]acrylate (10f). Method A, 
reaction period: 40 min. Recrystallization from diisopropyl ether. Yield: 45%. Brownish 
crystalline powder, mp 170-171 °C. IR: νmax 2982, 1712 (C=O, ester), 1653 (C=O, ketone), 1616 
(C=C), 1471, 1407, 1389 (flavone skeleton), 1296, 1285, 1272 (C-O-C), 1208, 1173, 1094, 762 
cm-1; 1H NMR: δ 1.27 (t, J = 7.0 Hz, 3H, CH3CH2), 4.18 (q, J = 7.0 Hz, 2H, CH3CH2), 7.38 (d, J 
= 15.5 Hz, 1H, β-H), 7.44-7.55 (m, 6H, Αr-H, α-H), 7.69 (m, 2H, 2’,6’-H), 8.27 (d, J = 8.4 Hz, 
1H, 5-H); 13C-NMR: δ  14.2 (CH3CH2), 60.3 (CH3CH2), 115.6 (C-3), 117.8 (C-8), 123.3 (C-4a), 
123.9 (C-2”), 125.6, 126.3 (C-5, C-6), 129.0, 131.1 (C-2’,6’, C-3’,5’), 134.0, 135.4 (C-7, C-3”), 
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137.5, 137.8 (C-1’, C-4’), 155.1 (C-8a), 165.3, 167.7 (C-2, C-1”), 176.6 (C-4). Anal. Calcd. for 
C20H15ClO4 (354.79): C, 67.71; H 4.26%. Found: C, 67.55; H, 4.29%.  
(E)-6-Styrylflavone (15a). Method A, reaction period: 60 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 87%. Yellow crystalline 
powder, mp 186-187 °C. IR: νmax 3057, 3012, 1645 (C=O), 1615 (C=C), 1596, 1568, 1497, 1452, 
1434, 1364 (flavone skeleton), 1238, 976, 907, 844, 811, 771, 692 cm-1; 1H NMR: δ 6.80 (s, 1H, 
3-H), 7.08, 7.16 (AB q, J = 16.2 Hz, 2H, α-H, β-H), 7.27-7.36 (m, 3H, 3’,5’-H, 4”-H), 7.53-7.58 
(m, 6H, Ar-H), 7.80 (d, J = 8.3 Hz, 1H, 7-H), 7.88 (m, 2H, 2”,6”-H), 8.28 (s, 1H, 5-H); 13C-
NMR: δ 107.4 (C-3), 118.4 (C-8), 122.8 (C-4’), 123.9 (C-4a), 126.2, 126.6 (C-3’,5’, C-3”,5”), 
126.5 (C-4”), 127.9 (C-α), 128.7, 128.9  (C-2’,6’, C-2”, 6”), 130.1 (C-β), 131.5, 131.6  (C-5, C-
7), 131.6 (C-1’), 134.6 (C-6), 136.7 (C-1”), 155.4 (C-8a), 163.1 (C-2), 178.2 (C-4). Anal. Calcd. 
for C23H16O2 (324.38): C, 85.16; H, 4.97%. Found: C, 85.00; H, 4.81%. 
(E)-6-(4-Methylstyryl)flavone (15b). Method A, reaction period: 40 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 88%. Yellow crystalline 
powder, mp 205-206 °C. IR: νmax 3060, 3027, 1638 (C=O), 1613 (C=C), 1568, 1483, 1452, 1438, 
1362 (flavone skeleton), 823, 772 cm-1; 1H NMR: δ 2.35 (s, 3H, CH3), 6.80 (s, 1H, 3-H); 7.04-
7.17 (m, 4H, α-Η, β-H, 3”,5”-H), 7.39 (d, J = 8.4 Hz, 2H, 2”,6”-H), 7.41-7.52 (m, 4H, 8-H, 
3’,5’-H, 4’-H), 7.78 (d, J = 8.4 Hz, 1H, 7-H), 7.88 (d, J = 7.7 Hz, 2H, 2’,6’-H), 8.27 (s, 1H, 5-H); 
13C-NMR: δ 21.2 (CH3), 107.4 (C-3), 118.3 (C-8), 122.6 (C-α), 123.9 (C-4a), 125.6 (C-4’), 
126.2, 126.5 (C-3’,5’, C-3”,5”), 128.9, 129.4  (C-2’,6’, C-2”,6”), 130.1 (C-β), 131.5, 131.6 (C-5, 
C-7), 131.7 (C-1’), 134.0, 134.9 (C-6, C-1”), 138.0 (C-4”), 155.4 (C-8a), 163.1 (C-2), 178.2 (C-
4). Anal. Calcd. for C24H18O2 (324.38): C, 85.18; H, 5.36%. Found: C, 85.01; H, 5.25%. 
 (E)-6-(4-Methoxystyryl)flavone (15c). Method A, reaction period: 30 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 41%. Yellow crystalline 
powder, mp 198-200 °C. IR: νmax 3063, 2840 (CH3O), 1651 (C=O), 1614 (C=C), 1603, 1513, 
1454, 1358 (flavone skeleton), 1304, 1269, 1255 (C-O-C), 1174, 1026 (C-O-C), 824 cm-1; 1H 
NMR: δ 3.81 (s, 3H, CH3O), 6.80 (s, 1H, 3-H), 6.88 (d, J = 8.4 Hz, 2H, 3”,5”-H), 6.98 (d, J = 
16.2 Hz, 1H, β-H), 7.14 (d, J = 16.1 Hz, 1H, α-H), 7.43-7.52 (m, 8H, Ar-H), 7.77 (d, J = 8.4 Hz, 
1H, 7-H), 7.89 (m, 2H, 2’, 6’-H), 8.25 (s, 1H, 5-H); 13C-NMR: δ 55.2 (CH3O), 107.3 (C-3), 
114.1 (C-3”,5”), 118.3 (C-8), 122.3 (C-α), 123.9 (C-4a), 124.5 (C-4’), 126.2 (C-3’,5’), 127.8, 
128.9 (C-2’,6’, C-2”,6”), 129.5 (C-1”), 129.7 (C-β), 131.5 (C-5, C-7), 131.6 (C-1’), 135.0 (C-6), 
155.2 (C-8a), 159.5 (C-4”), 163.1 (C-2), 178.3 (C-4). Anal. Calcd. for C24H18O3 (354.41): C, 
81.34; H, 5.12%. Found: C, 81.19; H, 5.01%. 
 (E)-6-(4-Chlorostyryl)flavone (15d). Method A, reaction period: 30 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 87%. Pale yellow crystalline 
powder, mp 202-203 °C. IR: νmax 3057, 1640 (C=O), 1613 (C=C), 1567, 1492, 1452, 1362 
(flavone skeleton), 1092, 826, 772 cm-1; 1H NMR: δ 6.80 (s, 1H, 3-H), 7.04, 7.09 (AB q, J = 16.8 
Hz, 2H, α-H, β-H), 7.30 (d, J = 8.4 Hz, 2H, 3”, 5”-H), 7.40 (d, J = 8.4 Hz, 2H, 2”, 6”-H), 7.52 
(m, 4H, 8-H, 3’,5’-H, 4’-H), 7.77 (d, J = 8.4 Hz, 1H, 7-H), 7.88 (d, J = 7.0 Hz, 2H, 2’,6’-H), 8.26 
(s, 1H, 5-H); 13C-NMR: δ 107.4 (C-3), 118.5 (C-8), 122.9 (C-α), 124.0 (C-4a), 126.2 (C-3’,5’), 
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127.2 (C-4’), 127.7 (C-3”,5”), 128.8 (C-β), 128.9, 129.0 (C-2’,6’, C-2”,6”), 131.6, 131.7 (C-5, 
C-7), 133.5, 134.3, 135.2   (C-6, C-1’, C-1”), 155.6 (C-8a), 163.2 (C-2), 178.1 (C-4). Anal. 
Calcd. for C23H15ClO2 (358.82): C, 76.99; H, 4.21%. Found: C, 77.17; H, 4.13%. 
(E)-6-(3-Hidroxy-3-methylbut-1-enyl)flavone (15e). Method A, reaction period: 30 min. 
Purified by column chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 87%. White 
crystalline powder, mp 115-117 °C. IR: νmax 3443 (OH), 3059, 2976, 1643 (C=O), 1613 (C=C), 
1570, 1496, 1486, 1450, 1435, 1362 (flavone skeleton), 1237 (C-OH), 1150, 969, 901, 892, 822, 
772 cm-1; 1H NMR: δ 1.45 (s, 6H, 2xCH3), 2.05 (s, 1H, OH), 6.45 (d, J = 16.1 Hz, 1H, 2”-H), 
6.65 (d, J = 16.1 Hz, 1H, 1”-H), 6.79 (s, 1H, 3-H), 7.47 (m, 4H, 8-H, 3’,5’-H, 4’-H), 7.67 (d, J = 
8.4 Hz, 1H, 7-H), 7.88 (d, J = 7.7 Hz, 2H, 2’,6’-H), 8.17 (s, 1H, 5-H); 13C-NMR: δ 29.8 
(2xCH3), 70.9 (C-3”), 107.3 (C-3), 118.2 (C-8), 122.7 (C-1”), 123.8 (C-4a), 124.6 (C-4’), 126.1 
(C-3’,5’), 128.9 (C-2’,6’), 131.5, 131.8  (C-7, C-2”), 131.6 (C-1), 134.4 (C-6), 139.3 (C-5), 
155.3 (C-8a), 163.2 (C-2), 178.3 (C-4). Anal. Calcd. for C20H18O3 (306.36): C, 78.41; H, 5.92%. 
Found: C, 78.52; H, 6.03%. 
Ethyl (E)-6-(2-phenyl-4-oxo-4H-1-benzopyran-3-yl)acrylate (15f). Method B, reaction period: 
300 min. Recrystallization from hexane – abs. ethanol. Yield: 32%. Brownish crystalline 
powder, mp 145-146 °C. IR: νmax 3079, 2978, 1711 (C=O, ester), 1636 (C=O, ketone), 1607 
(C=C), 1568, 1496, 1483, 1453, 1358 (flavone skeleton), 1306, 1238, 1219 (C-O-C), 1197, 1176, 
1137, 1032, 1024 (C-O-C), 987 (HC=CH, trans), 908, 827, 772 cm-1; 1H NMR: δ 1.33 (t, J = 7.0 
Hz, 3H, CH3CH2), 4.25 (q, J = 7.0 Hz, 2H, CH3CH2), 6.49 (d, J = 16.1 Hz, 1H, 2-H), 6.54 (s, 
1H, 3’-H), 7.52-7.58 (m, 4H, 8’-H, 3”,5”-H, 4”- H), 7.71 (d, J = 16.1 Hz, 1H, 3-H), 7.81 (dd, J = 
8.4 Hz, 2.1 Hz, 1H, 7-H), 7.89 (dd, J = 8.4 Hz, 1.8 Hz, 2H, 2”,6”-H), 8.34 (s, 1H, 5’-H); 13C-
NMR: δ 14.2 CH3CH2), 60. CH3CH2), 107.6 (C-3’), 118.8, 119.7 (C-2, C-8’), 124.0 (C-4a’), 
125.5 (C-4”), 126.2 (C-3”,5”), 129.0 (C-2”,6”), 131.4, 131.7 (C-1’, C-1”), 131.8, 132.6 (C-3, C-
7’), 142.4 (C-5’), 156.8 (C-8a’), 163.4 (C-2’), 166.4 (C-1), 177.7 (C-4’). Anal. Calcd. for 
C20H16O4 (320.34): C, 74.99; H, 5.03%. Found: C, 75.21; H, 5.03%. 
(E)-7-Styrylflavone (16a). Method A, reaction period: 60 min. Recrystallization from hexane – 
abs. ethanol. Yield: 65%. Brownish crystalline powder, mp 153-154 °C. IR: νmax 3058, 3020, 
1654 (C=O), 1618 (C=C), 1606, 1448, 1428, 1367, 1358 (flavone skeleton),  964 (CH=CH, 
trans), 770 cm-1; 1H NMR: δ 6.79 (s, 1H, 3-H), 7.12 (d, J = 16.3 Hz, 1H, β-H); 7.30 (d, J = 16.3 
Hz, 1H, α-H), 7.31-7.41 (m, 3H, 3”,5”-H, 4”-H), 7.53-7.61 (m, 7H, Ar-H), 7.90 (d, J = 7.7 Hz, 
2H, 2’,6’-H), 8.17 (d, J = 8.4 Hz, 1H, 5-H); 13C-NMR: δ 107.6 (C-3), 115.3 (C-8), 122.8 (C-4a), 
123.2 (C-4’), 125.9 (C-α), 126.2, 126.8 (C-3’,5’, C-3”,5”), 126.7 (C-6), 128.5 (C-4”), 128.8, 
128.9 (C-2’,6’, C-2”,6”), 131.5 (C-β), 131.7 (C-1’), 132.4 (C-5), 136.3 (C-1”), 143.1 (C-7), 
156.6 (C-8a), 163.2 (C-2), 177.9 (C-4). Anal. Calcd. for C23H16O2 (324.38): C, 85.16; H, 4.97%. 
Found: C, 85.31; H, 4.80%. 
(E)-7-(4-Methylstyryl)flavone (16b). Method A, reaction period: 60 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 92%. Yellow crystalline 
powder, mp 189-190 °C. IR: νmax 3056, 3022, 2917 (C-H), 1636 (C=O), 1618 (C=C), 1604, 
1449, 1430, 1371 (flavone skeleton), 960 (HC=CH, trans), 826 cm-1; 1H NMR: δ 2.36 (s, 3H, 
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CH3), 6.77 (s, 1H, 3-H), 7.05 (d, J = 16.1 Hz, 1H, β-H), 7.17-7.21 (m, 3H, β-H, 3”,5”-H), 7.41 
(d, J = 7.7 Hz, 2H, 2”,6”-H); 7.50-7.56 (m, 5H, 6-H, 8-H, 3’,5’-H, 4’-H); 7.89 (d, J = 7.7 Hz, 
2H, 2’,6’-H), 8.14 (d, J = 8.4 Hz, 1H, 5-H); 13C-NMR: δ 21.3 (CH3), 107.6 (C-3), 115.1 (C-8), 
122.7 (C-4a), 123.2 (C-4’), 125.7, 125.8 (C-6, C-α), 126.2, 126.8 (C-3’,5’, C-3”,5”), 129.0, 
129.5 (C-2’,6’, C-2”,6”), 131.5, 132.4 (C-β, C-5), 131.8 (C-1’), 133.5 (C-1”), 138.6 (C-4”), 
143.4 (C-7), 156.6 (C-8a), 163.2 (C-2), 177.9 (C-4). Anal. Calcd. for C24H18O2 (324.38): C, 
85.18; H, 5.36%. Found: C, 85.12; H, 5.48%. 
(E)-7-(4-Methoxystyryl)flavone (16c). Method A, reaction period: 40 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 89%. Yellow crystalline 
powder, mp 184-185 °C. IR: νmax 3063, 3030, 2837 (CH3O), 1642 (C=O), 1620 (C=C), 1599, 
1574, 1509, 1452, 1431, 1417, 1373 (flavone skeleton), 1302, 1251 (C-O-C), 1172, 1030 (C-O-
C), 960 (HC=CH, trans), 824 cm-1; 1H NMR: δ 3.83 (s, 3H, CH3O), 6.77 (s, 1H, 3-H), 6.90 (d, J 
= 8.4 Hz, 2H, 3”,5”-H); 6.96 (d, J = 16.1 Hz, 1H, α-H), 7.19 (d, J = 16.1 Hz, 1H, β-H), 7.46-
7.55 (m, 7H, Ar-H), 7.89 (m, 2H, 2’,6’-H), 8.14 (d, J = 7.7 Hz, 1H, 5-H); 13C-NMR: δ 55.3 
(CH3O), 107.6 (C-3), 114.2 (C-3”,5”), 114.9 (C-8), 122.5 (C-4a), 123.0 (C-α), 124.5, 125.8 (C-6, 
C-4’), 126.1 (C-3’,5’), 128.2, 128.9  (C-2’,6’, C-2”,6”), 129.0 (C-1”), 131.5, 132.0 (C-5, C-β), 
131.8 (C-1’), 143.5 (C-7), 156.6 (C-8a), 160.0 (C-4”), 163.1 (C-2), 177.9 (C-4). Anal. Calcd. for 
C24H18O3 (354.41): C, 81.34; H, 5.12%. Found: C, 81.23; H, 4.98%. 
(E)-7-(4-Chlorostyryl)flavone (16d). Method A, reaction period: 90 min. Purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 68%. Yellow crystalline 
powder, mp 209-210 °C. IR: νmax 3053, 3026, 1624 (C=O + C=C), 1559, 1486, 1451, 1436, 1374 
(flavone skeleton), 1243, 1082, 954 (HC=CH, trans), 910, 817, 810, 768 cm-1; 1H NMR: δ
 
6.78 
(s, 1H, 3-H), 7.08, 7.20 (AB q, J = 16.0 Hz, 2H, α-H, β-H), 7.33 (d, J = 8.1 Hz, 2H, 3”,5”-H), 
7.43 (d, J = 8.1 Hz, 2H, 2”,6”-H), 7.51-7.56 (m, 4H, 6-H, 3’,5’-H, 4’-H), 7.57 (s, 1H, 8-H), 7.88 
(m, 2H, 2’,6’-H), 8.15 (d, J = 7.9 Hz, 1H, 5-H); 13C-NMR: δ 107.7 (C-6), 115.4 (C-8), 123.0 (C-
4a), 123.2 (C-α), 125.9 (C-6), 126.1 (C-3”,5”), 127.2 (C-4’), 128.0 (C-3’,5’), 128.9 (C-2’,6’, C-
2”,6”), 131.0, 131.5 (C-5, C-β), 131.7 (C-1’), 134.2, 134.8 (C-1”, C-4”), 142.7 (C-7), 156.6 (C-
8a), 163.3 (C-2); 177.8 (C-4). Anal. Calcd. for C23H15ClO2 (358.82): C, 76.99; H, 4.21%. Found: 
C, 76.84; H, 4.35%.
 
(E)-7-(3-Hidroxy-3-methylbut-1-enyl)flavone (16e). Method A, reaction period: 40 min. 
Purified by column chromatography (eluent: hexane-ethyl acetate = 1:1, v/v). Yield: 76%. White 
crystalline powder, mp 175-176 °C. IR: νmax 3385 (OH), 3057, 3003, 1628 (C=O + C=C), 1591, 
1573, 1450, 1376 (flavone skeleton), 1232 (C-OH), 969 (CH=CH, trans), 909, 770 cm-1; 1H 
NMR: δ
 
 1.47 (s, 6H, 2xCH3), 2.20 (s, 1H, OH), 6.53, 6.66  (AB q, J = 16.1 Hz, 2H, α-H, β-H), 
6.78 (s, 1H, 3-H), 7.38 (d, J = 8.4 Hz, 1H, 6-H), 7.46 (s, 1H, 8-H), 7.50-7.51 (m, 3H, 3’,5’-H, 4’-
H), 7.88 (d, J = 7.7 Hz, 2H, 2’,6’-H), 8.11 (d, J = 8.4 Hz, 1H, 5-H); 13C-NMR: δ 29.7 (2xCH3), 
70.9 (C-3”), 107.5 (C-3), 115.3 (C-8), 122.6 (C-4a), 123.2 (C-1”), 124.8, 125.7 (C-6, C-4’), 
126.1 (C-3’,5’), 128.9 (C-2’,6’), 131.5 (C-2”), 131.6 (C-1’), 141.7 (C-5), 143.0 (C-7), 156.5 (C-
8a), 163.2 (C-2), 178.1 (C-4). Anal. Calcd. for C20H18O3 (306.36): C, 78.41; H, 5.92%. Found: 
C, 78.39; H, 6.07%. 
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Ethyl (E)-7-(2-phenyl-4-oxo-4H-1-benzopyran-3-yl)acrylate (16f). Method B, reaction period: 
150 min. Recrystallization from hexane – abs. ethanol. Yield: 84%. Brownish crystalline 
powder, mp 167-168 °C. IR: νmax 3059, 2980, 1712 (C=O, ester), 1654 (C=O, ketone), 1620 
(C=C), 1606, 1559, 1449, 1369 (flavone skeleton), 1287, 1245, 1185, 1145, 1035, 998 (HC=CH, 
trans), 772, 686 cm-1; 1H NMR: δ
 
 1.34 (t, J = 7.0 Hz, 3H, CH3CH2), 4.27 (q, J = 7.0 Hz, 2H, 
CH3CH2), 6.60 (d, J = 16.1 Hz, 1H, 2-H), 6.83 (s, 1H, 3’-H), 7.53-7.58 (m, 4H, 6’-H, 3”,5”-H, 
4”-H), 7.68 (s, 1H, 8’-H), 7.74 (d, J = 16.1 Hz, 1H, 3-H), 7.92 (d, J = 7.7 Hz, 2H, 2”,6”-H), 8.22 
(d, J = 8.4 Hz, 1H, 5’-H); 13C-NMR: δ 14.3 (CH3CH2), 60.9 (CH3CH2), 107.8 (C-3’), 117.7 (C-
8’), 121.9 (C-2), 124.1 (C-4”), 124.6 (C-4a’), 126.3 (C-3”,5”), 126.3 (C-6’), 129.1 (C-2”,6”),  
131.5 (C-1”), 131.7 (C-3), 139.8 (C-7’), 142.2 (C-5’), 156.3 (C-8a), 163.6 (C-2’), 166.2 (C-1), 
177.7 (C-4). Anal. Calcd. for C20H16O4 (320.34): C, 74.99; H, 5.03%. Found: C, 75.05; H, 
4.89%. 
 (E)-6-(2-phenyl-4-oxo-4H-1-benzopyran-3-yl)acrylaldehyde (18) and ethyl (E)-6-(2-phenyl-
4-oxo-4H-1-benzopyran-3-yl)propionate (19). 6-Bromoflavone (13) (376 mg, 1.249 mmol) 
was reacted with acrolein diethyl acetal (17) (0.95 mL, 811 mg, 6.232 mmol) under Conditions A 
at 110 oC. Although the reaction was not complete after 4 hours it was interrupted due to the 
increase of decomposition and worked-up as usual. The crude product was purified by column 
chromatography (eluent: hexane-ethyl acetate = 1:1, v/v) to give 146 mg of unreacted starting 
material 13, 146 mg (59%) of ester 19 and 36 mg (17%) of aldehyde 18 in their elution order. 
Yields were corrected with the recovered starting material. Compound 18. Mp 180-182 oC. IR: 
νmax 1678 (C=O, aldehyde), 1644 (C=O, ketone), 1609 (C=C), 1452, 1356 (flavone skeleton), 
1122, 913, 744 cm-1; 1H NMR: δ
 
6.84 (dd, J = 15.8 Hz, 7.6 Hz, 1H, 2-H), 6.91 (s, 1H, 3’-H), 
7.59-7.64 (m, 5H, 3-H, 8’-H, 3”,5”-H, 4”-H), 7.69 (d, J = 9.0 Hz, 1H, 7’-H), 7.98 (m, 2H, 2”,6”-
H), 8.45 (s, 1H, 5’-H), 9.80 (d, J = 7.6 Hz, 1H, 1-H); 13C-NMR: δ 107.9 (C-3’), 119.3 (C-8’), 
124.2 (C-4a’), 126.2 (C-3”,5”), 126.9 (C-4”), 129.1 (C-2”,6”), 129.6 (C-5’), 131.3 (C-6”, C-1”), 
132.0, 132.4 (C-2, C-7’), 150.4 (C-3), 157.5 (C-8a’), 163.7 (C-2’), 177.7 (C-4’), 193.2 (C-1).  
Anal. Calcd. for C18H12O3 (276.29): C, 78.25; H, 4.38%. Found: C, 78.11; H, 4.50%. Compound 
19. Mp 75-76 oC. IR: νmax 3060, 2981, 1730 (C=O, ester), 1650 (C=O, ketone), 1620 (C=C), 
1571, 1485, 1456, 1380, 1366 (flavone skeleton), 1286 (C-O-C), 1175, 775, 690 cm-1; 1H NMR: 
δ 1.25 (t, J = 6.8 Hz, 3H, CH3CH2), 2.70 (t, J = 7.6 Hz, 2H, 2-H), 3.07 (t, J = 7.6 Hz, 2H, 3-H), 
4.13 (q, J = 6.8 Hz, 2H, CH3CH2), 6.82 (s, 1H, 3’-H), 7.50-7.58 (m, 5H, 7’-H, 8’-H, 3”,5”-H, 4”-
H), 7.92 (m, 2H, 2”,6”-H), 8.06 (s, 1H, 5’-H); 13C-NMR: δ 14.2 (CH3CH2), 30.3 (C-3), 35.6 (C-
2), 60.5 (CH3CH2), 107.4 (C-3’), 118.2 (C-8’), 123.8 (C-4a’), 124.5 (C-4”), 126.2 (C-3”,5”), 
129.0 (C-2”,6”), 131.5 (C-5’), 131.8 (C-1”), 134.4 (C-5’), 134.4 (C-7’), 137.9 (C-6’), 154.9 (C-
8a’), 136.3 (C-2’), 172.5 (C-1), 178.4 (C-4’). Anal. Calcd. for C20H18O4 (322.36): C, 74.52; H, 
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